The European Medical Device Regulation is bringing significant changes from the Directives it is replacing. The new EU Medical Device Regulation (MDR 2017/745) was published in May 2017 and the clock of the 3-year mandatory transitional period has started since then. Click here to read more.
Peri and post-approval research environment is challenging, quickly evolving and has limited secure global gold standards.
Late phase research requires anticipation and agility, regulatory intelligence, innovative designs and methods to deliver fit for purpose outcomes and meet stakeholders needs. Click here to read more.
Risk based approach is a one of the key drivers to optimise quality in Clinical Trials. This requires an adequate design and plan, an engagement of all parties, Sponsor and Investigator and an alignment with regulatory expectations. Click here to read more.
The emergence of patient centric approaches, digital strategies, as well as responsible data sharing policies, has generated a new issue: to protect sensitive personal data while maximising its value for innovation. Read more...
The adoption of new technologies in clinical research remains complex raising numerous questions and issues with limited guidance being available. Read more...
The “coming into effect” of the EU Clinical Trials Regulation 536/2014 is approaching, despite delays. A number of supplementary guidelines have been published in EudraLex Volume 10 and the EU Portal is being worked on feverously. Read more...
Dear Friends and Colleagues,
It is a great pleasure to invite you to attend the 4th European Conference on Clinical Research to be held on Monday 26th and Tuesday 27th February in Vienna, Austria.
The theme of the 2018 Conference ‘Are You Ready to Embrace the Changes’ will underpin the need for knowing, understanding and adhering to the multiple regulatory requirements, guidance documents and systems, which are being released in Europe. The “Programme at a glance” will give you an overview of the topics that will be explored during these 2 days.
The conference will provide multiple opportunities to meet your professional interests and needs, and create a wonderful forum for you to discuss your transition readiness.
The conference will take place in an attractive, historic and central location. You’ll have numerous networking opportunities, be able to meet and interact with the leading experts, regulators, patients and patient representatives, friends and colleagues as well as sponsors and exhibitors.
Vienna is an exciting and easy to reach location for the conference and a very traditional social Programme, including culinary aspects in a relaxing atmosphere, are waiting for you.
We hope you will join us for this firework of outstanding presentations and take a little extra time to enjoy the spectacular beauty of this city and region. We would be honoured and delighted to welcome you in Vienna.
With kind Regards,
Dr. Martine Dehlinger-Kremer
You can reach the Onsite Registration Desk at +420 727 803 209
We are looking forward to meeting you in Vienna.